Dr. Lally specializes in the care of patients with various rheumatic conditions including vasculitis, systemic lupus erythematosus, scleroderma and rheumatoid arthritis and has a particular interest in the systemic vasculitides. Dr. Lally is actively involved as an investigator in numerous clinical and translational studies focusing on vasculitis and has been the recipient of several awards including a Vasculitis Foundation Research Grant and the American College of Rheumatology Distinguished Fellow Award.
Dr. Lally received her Bachelor of Arts from Princeton University and her medical degree from Weill Cornell Medical College. She completed her residency in Internal Medicine at NewYork-Presbyterian Hospital - Weill Cornell Medical Center followed by her Rheumatology Fellowship at Hospital for Special Surgery.
Assistant Attending Rheumatologist, Hospital for Special Surgery
Assistant Professor of Medicine, Weill Cornell Medical College
Connective Tissue Disease
Systemic Lupus Erythematosus/Antiphospholipid Antibody Syndrome
Intra-articular and intra-bursal aspirations and injections
Vasculitis Foundation Research Grant, 2013
American College of Rheumatology Distinguished Fellow Award, 2013
Weill Cornell Alumni Organization Distinguished Housestaff Award, 2010
William C. Thro Memorial Prize for pathophysiology, 2008
Alpha Omega Alpha Honor Society, 2007
Blue Cross HMO POS
Blue Cross PPO
Blue Cross Pathway
Blue Cross Pathway Enhanced
Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may still have coverage subject to the availability of 'out-of-network' benefits.
One of the goals of Hospital for Special Surgery (HSS) is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of August 15, 2014, Dr. Lally reported no financial interest relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
MD, Weill Cornell Medical College, New York, 2008
Internal Medicine, NewYork-Presbyterian Hospital-Cornell
Internal Medicine, NewYork-Presbyterian Hospital-Cornell
Hospital for Special Surgery, NY
Lally L, Paget S. Clinical Approach to Patients with Vasculitis. In: The Vasculitidies: General Considerations and Systemic Vasculitis. (Ed Younger D) Nova Scientific, 2014.
Lally L, Spiera RF. Vasculitis in Pregnancy. In: Contraception and Pregnancy in Patients with Rheumatic Disease. (Ed Sammaritano LR and Bermas BL) Springer, 2014.
Erkan D, Lally L, and Lockshin M. What Should Patients Know about Antiphospholipid Antibodies and Antiphospholipid Syndrome? In: Antiphospholipid Syndrome: Insights and Highlights from the 13th International Congress on Antiphospholipid Antibodies. (Eds Erkan D and Pierangeli S) Springer, 2012.
Lally L, Spiera RF. Current Landscape of ANCA-Associated Vasculitis: Classification, Diagnosis and Treatment . Rheum Dis Clin North Am. 2015;41(1):1-19.
Lally L, Sammaritano LR. Vasculitis in Antiphospholipid syndrome. Rheum Dis Clin North Am. 2015;41(1):109-23.
Lally L, Spiera RF. Current therapies for ANCA-associated vasculitis. Annual Review of Medicine 2014, volume 66 in press
Lally L, Pernis A, Narula N, Huang WT and Spiera RF. Increased Rho Kinase Activity in Temporal Artery Biopsies from Patients with Giant Cell Arteritis. Rheumatology (Oxford) 2014.
Lally L, Lebovics RS, Huang-WT, Spiera RF. Effectiveness of rituximab for the otolaryngologic manifestations of granulomatosis with polyangitiitis. Arthritis Care Res 2014;66(9)1403-9.
Lally L, Spiera RF. Biomarkers in ANCA-Associated Vasculitis. Curr Rheumatol Rep. 2013;15:363
For more publications, please see the PubMed listing.
Increased Rho Kinase (ROCK) Activity in Temporal Arterial Biopsies from Patients with Giant Cell Arteritis (GCA), American College of Rheumatology Annual Scientific Meeting, San Diego, CA, Oct 25-30, 2013. oral presentation
Efficacy of Rituximab for Otolaryngologic (ENT) Manifestations of Granulomatosis with Polyangiitis (GPA, Wegener’s granulomatosis), American College of Rheumatology Annual Scientific Meeting, San Diego, CA, Oct 25-30, 2013. poster presentation
Increased Rho Kinase (ROCK) Activity in Temporal Arterial Biopsies from Patients with Giant Cell Arteritis (GCA). International Giant Cell Arteritis, Polymyalgia Rheumatica and Large Vessel Vasculitis Symposium, Southend, UK November 2013 oral presenation
Rho Kinase (ROCK) Activity in Aortitis: Comparison of Giant Cell Arteritis, Takayasu Arteritis, and Isolated Aortitis. American College of Rheumatology Annual Scientific Meeting, Boston, MA, Nov 16-19, 2014. poster presentation